semaglutide and type 1 diabetes in Early Semaglutide in the Management of

[DOI] [PubMed] [Google Scholar] 140.Filippatos TD, Elisaf MS

Conclusion : Semaglutide, initially developed for the management of type 2 diabetes and obesity, offers a wide range of health benefits beyond its primary indications

Reducing GLP-1 side effects: Whats proven and whats not Nearly half of people taking GLP-1 medicines experience digestive issues such as nausea, vomiting or diarrhea

The publication references Sikiric et al., 2018, in connection with preclinical discussion of VEGFR2 signaling and nitric oxide system pathways

If side effects are troublesome, discuss alternatives with your prescriber rather than stopping treatment independently

This is also referred to as the maintenance dose